Trial Profile
Evaluation of Safety, Tolerability, and Pharmacokinetic Characteristics of DA-6034 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2016
Price :
$35
*
At a glance
- Drugs Recoflavone (Primary)
- Indications Dry eyes; Gastritis
- Focus Adverse reactions; First in man
- Sponsors Dong-A Pharmaceutical
- 15 Dec 2013 New trial record